Changes in intravenous fluid use patterns in Australia and New Zealand: evidence of research translating into practice

AuthorsGlassford, N.J.
French, C.J.
Bailey, M.
Martensson, J.
Eastwood, G.M.
Bellomo, R.
TypeJournal Article (Original Research)
JournalCritical care and resuscitation
PubMed ID27242105
Year of Publication2016
URLhttp://www.ncbi.nlm.nih.gov/pubmed/27242105
Download Lee_et_al-2016-Journal_of_Sleep_Research.pdf (82.8 KB)
AbstractOBJECTIVES: To describe changes in the use of intravenous (IV) fluid by quantity and type in different regions of Australia and New Zealand. DESIGN, SETTING AND PARTICIPANTS: We conducted a retrospective ecological study examining regional and temporal trends in IV fluid consumption across Australia and New Zealand over the periods 2012-2013 and 2013- 2014, using national proprietary sales data as a surrogate for consumption, and demographic data from the public domain. RESULTS: More than 13.3 million litres of IV fluid were consumed in Australia and New Zealand in 2012-2013, and more than 13.9 million litres in 2013-2014, with colloid solutions accounting for < 2%. There was marked regional variation in consumption of fluids, by volumes and proportions used, when standardised to overall Australian and New Zealand values. There was no significant change in the overall volume of crystalloid solutions consumed but there was a significant decrease (9%; P = 0.02) in the ratio of unbalanced to balanced crystalloid solutions consumed. Consumption of all forms of colloid solutions decreased, with a 12% reduction overall (P = 0.02), primarily driven by a 67% reduction in the consumption of hydroxyethyl starch (HES) solutions. CONCLUSIONS: The amount and type of IV fluid use, as determined by fluid sales, is highly variable across Australia and New Zealand. However, overall use of balanced crystalloid solutions is increasing and the use of HES has decreased dramatically.

http://www.ibas.org.au/what-we-do/publications/3872825


< More publications



ARIELARIEL

Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding a bike, can help...

Shift work and breastfeeding projectSHIFT WORK AND BREASTFEEDING PROJECT

Researchers at Austin Health are looking for volunteers to participate in a study exploring the impact shift work has on breast milk composition. Participants will be compensated with a $100 gift voucher.

Notch monitoring in sleepNOTCH MONITORING IN SLEEP

Sleep apnea is a condition where breathing is abnormal during sleep. There are two main forms of sleep apnea: obstructive and central. For obstructive sleep apnea, breathing is reduced because the airway...

A/Prof Mark Howard Awarded Major Competitive MRFF GrantA/PROF MARK HOWARD AWARDED MAJOR COMPETITIVE MRFF GRANT

IBAS leads project to revolutionize Home Ventilation with $1.2 million grant for Assoc. Prof Mark Howard's research titled "Synchronise non-invasive ventilation at home".

Prof Anne Holland receives prestigious Research AwardPROF ANNE HOLLAND RECEIVES PRESTIGIOUS RESEARCH AWARD

Prof Anne Holland receives prestigious award for Excellent in Research Engagement and Impact from Monash University.

World Sleep Day on 17th March 2023WORLD SLEEP DAY ON 17TH MARCH 2023

The benefits of quality sleep and to acknowledge the issue of sleep problems and their medical, educational, and social aspects as well as the prevention and management of sleep disorders, is promoted on World Sleep Day on the 17th March 2023.

A/Prof Mark Howard is listed in 'the Australian'A/PROF MARK HOWARD IS LISTED IN 'THE AUSTRALIAN'

The Australian's Research magazine names the top researcher and top research institution in each field of research, based on the number of citations for papers published in the top 20 journals in each field over the past five years.

Institute for Breathing and Sleep

Level 5, Harold Stokes Building, Austin Health
145 Studley Road
Heidelberg, Victoria, 3084

(03) 9496 5390

Email Us

Donate